R R Love

Summary

Affiliation: University of Wisconsin
Country: USA

Publications

  1. ncbi request reprint Cancer prevention services and physician consensus in primary care group practices
    Richard R Love
    Department of Family Medicine and Practice, School of Medicine, University of Wisconsin, Madison, WI 53726 2397, USA
    Cancer Epidemiol Biomarkers Prev 13:958-66. 2004
  2. ncbi request reprint Breast cancer from a public health perspective
    Richard R Love
    Department of Medicine, University of Wisconsin, and University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, USA
    Breast J 10:136-40. 2004
  3. ncbi request reprint Duration of signs and survival in premenopausal women with breast cancer
    Richard R Love
    Department of Medicine, Section of Medical Oncology, University of Wisconsin School of Medicine, Madison, WI, USA
    Breast Cancer Res Treat 86:117-24. 2004
  4. ncbi request reprint Ornithine decarboxylase (ODC) as a prognostic factor in operable breast cancer
    Richard R Love
    Department of Medicine, Section of Medical Oncology, University of Wisconsin School of Medicine, Madison, WI, USA
    Breast Cancer Res Treat 79:329-34. 2003
  5. ncbi request reprint Postmastectomy radiotherapy in premenopausal Vietnamese and Chinese women with breast cancer treated in an adjuvant hormonal therapy study
    Richard R Love
    Department of Medicine, Section of Medical Oncology, University of Wisconsin School of Medicine, Madison, WI, USA
    Int J Radiat Oncol Biol Phys 56:697-703. 2003
  6. ncbi request reprint Her-2/neu overexpression and response to oophorectomy plus tamoxifen adjuvant therapy in estrogen receptor-positive premenopausal women with operable breast cancer
    Richard R Love
    Departments of Medicine and Biostatistics and Medical Informatics, University of Wisconsin, Madison, WI 53726, USA
    J Clin Oncol 21:453-7. 2003
  7. ncbi request reprint Models of breast cancer growth and investigations of adjuvant surgical oophorectomy
    Richard R Love
    Department of Medicine, University of Wisconsin School of Medicine, 610 Walnut St, 256 WARF Bldg, Madison, WI 53726 2397, USA
    Ann Surg Oncol 11:818-28. 2004
  8. ncbi request reprint Endocrine effects of tamoxifen plus exemestane in postmenopausal women with breast cancer
    Richard R Love
    Department of Medicine, University of Wisconsin, 610 Walnut Street, 256 Warf Office Building, Madison, WI 53726, USA
    Clin Cancer Res 11:1500-3. 2005
  9. ncbi request reprint Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancer
    Richard R Love
    University of Wisconsin Comprehensive Cancer Center, 610 Walnut Street, Madison, WI 53705 2397, USA
    J Clin Oncol 20:2559-66. 2002
  10. ncbi request reprint Mastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancer
    Richard R Love
    Department of Medicine, Section of Medical Oncology, University of Wisconsin School of Medicine, Madison, 53705, USA
    J Natl Cancer Inst 94:662-9. 2002

Research Grants

Detail Information

Publications35

  1. ncbi request reprint Cancer prevention services and physician consensus in primary care group practices
    Richard R Love
    Department of Family Medicine and Practice, School of Medicine, University of Wisconsin, Madison, WI 53726 2397, USA
    Cancer Epidemiol Biomarkers Prev 13:958-66. 2004
    ....
  2. ncbi request reprint Breast cancer from a public health perspective
    Richard R Love
    Department of Medicine, University of Wisconsin, and University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, USA
    Breast J 10:136-40. 2004
    ..Public health perspectives thus suggest that many current "standard" approaches to breast cancer in Western countries cannot help the majority of women in the world...
  3. ncbi request reprint Duration of signs and survival in premenopausal women with breast cancer
    Richard R Love
    Department of Medicine, Section of Medical Oncology, University of Wisconsin School of Medicine, Madison, WI, USA
    Breast Cancer Res Treat 86:117-24. 2004
    ..Overall survival, however, was not significantly different in these two groups...
  4. ncbi request reprint Ornithine decarboxylase (ODC) as a prognostic factor in operable breast cancer
    Richard R Love
    Department of Medicine, Section of Medical Oncology, University of Wisconsin School of Medicine, Madison, WI, USA
    Breast Cancer Res Treat 79:329-34. 2003
    ..Univariate, Kaplan-Meier and multivariate Cox analyses showed no evidence of relationships of ODC by H SCORE to disease-free or overall survival...
  5. ncbi request reprint Postmastectomy radiotherapy in premenopausal Vietnamese and Chinese women with breast cancer treated in an adjuvant hormonal therapy study
    Richard R Love
    Department of Medicine, Section of Medical Oncology, University of Wisconsin School of Medicine, Madison, WI, USA
    Int J Radiat Oncol Biol Phys 56:697-703. 2003
    ..Adjuvant postmastectomy radiotherapy (RT) decreases the risk of local recurrence of breast cancer and may increase overall survival (OS)...
  6. ncbi request reprint Her-2/neu overexpression and response to oophorectomy plus tamoxifen adjuvant therapy in estrogen receptor-positive premenopausal women with operable breast cancer
    Richard R Love
    Departments of Medicine and Biostatistics and Medical Informatics, University of Wisconsin, Madison, WI 53726, USA
    J Clin Oncol 21:453-7. 2003
    ....
  7. ncbi request reprint Models of breast cancer growth and investigations of adjuvant surgical oophorectomy
    Richard R Love
    Department of Medicine, University of Wisconsin School of Medicine, 610 Walnut St, 256 WARF Bldg, Madison, WI 53726 2397, USA
    Ann Surg Oncol 11:818-28. 2004
    ..Clinical trials and laboratory mechanistic investigations based on these data and observations can determine the potential impact of therapeutic interventions targeting host system macro and micro tumor cell environments...
  8. ncbi request reprint Endocrine effects of tamoxifen plus exemestane in postmenopausal women with breast cancer
    Richard R Love
    Department of Medicine, University of Wisconsin, 610 Walnut Street, 256 Warf Office Building, Madison, WI 53726, USA
    Clin Cancer Res 11:1500-3. 2005
    ..To evaluate the endocrine effects of the combination of exemestane and tamoxifen, we studied 33 postmenopausal women disease-free following primary treatments for breast cancer who were taking tamoxifen for at least 3 months...
  9. ncbi request reprint Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancer
    Richard R Love
    University of Wisconsin Comprehensive Cancer Center, 610 Walnut Street, Madison, WI 53705 2397, USA
    J Clin Oncol 20:2559-66. 2002
    ..Approximately 350,000 new cases of breast cancer are diagnosed annually in premenopausal Asian women who have lower levels of estrogen than western women...
  10. ncbi request reprint Mastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancer
    Richard R Love
    Department of Medicine, Section of Medical Oncology, University of Wisconsin School of Medicine, Madison, 53705, USA
    J Natl Cancer Inst 94:662-9. 2002
    ..We investigated this question in the context of a clinical trial comparing mastectomy alone with mastectomy plus adjuvant oophorectomy and tamoxifen in premenopausal women with operable breast cancer...
  11. ncbi request reprint Serum homocysteine levels in postmenopausal breast cancer patients treated with tamoxifen
    R R Love
    Department of Medicine, University of Wisconsin Medical School, Madison 53706, USA
    Cancer Lett 145:73-7. 1999
    ..After treatment with tamoxifen, we found lower levels of serum homocysteine of borderline statistical significance...
  12. ncbi request reprint Young age as an adverse prognostic factor in premenopausal women with operable breast cancer
    Richard R Love
    Department of Medicine, University of Wisconsin, University of Wisconsin Comprehensive Cancer Center, Madison, USA
    Clin Breast Cancer 2:294-8. 2002
    ..Thus, despite efficacy of the combined adjuvant hormonal therapy, younger age was a risk factor for poorer survival...
  13. ncbi request reprint Treatment of breast cancer in countries with limited resources
    Robert W Carlson
    Department of Medicine, Stanford University, Stanford, California 94305, USA
    Breast J 9:S67-74. 2003
    ..Efforts to reduce the number of breast cancers diagnosed at an advanced stage thus have the potential to improve rates of survival while decreasing the use of limited resources...
  14. ncbi request reprint alpha-difluoromethylornithine ototoxicity. Chemoprevention clinical trial results
    T R Pasic
    Division of Otolaryngology Head and Neck Surgery, University of Wisconsin, Madison, USA
    Arch Otolaryngol Head Neck Surg 123:1281-6. 1997
    ..To determine the effects of low-dose oral eflornithine hydrochloride (difluoromethylornithine [DFMO]) administration on hearing and to identify factors that influence those effects...
  15. ncbi request reprint Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer
    Howard H Bailey
    University of Wisconsin Paul P Carbone Comprehensive Cancer Center, 600 Highland Avenue K4 6 CSC, Madison, WI 53792, USA
    Cancer Chemother Pharmacol 62:149-57. 2008
    ..We conducted a phase II multi-institutional study of oral POH administered four times daily in women with advanced treatment-refractory breast cancer...
  16. ncbi request reprint Correlates of age at menarche among sixth grade students in Wisconsin
    Amy Trentham-Dietz
    University of Wisconsin Comprehensive Cancer Center, Madison, USA
    WMJ 104:65-9. 2005
    ..03) and participated in fewer hours of sporting activity (P=0.08) than students who had not yet reached menarche. These preliminary data suggest that further investigation of the determinants of menarche is both feasible and warranted...
  17. ncbi request reprint Effect of exemestane on tamoxifen pharmacokinetics in postmenopausal women treated for breast cancer
    Paul R Hutson
    School of Pharmacy, University of Wisconsin, Madison, Wisconsin 53705 2222, USA
    Clin Cancer Res 11:8722-7. 2005
    ..Clinical trials combining tamoxifen with letrozole or anastrazole have shown minor pharmacokinetic drug interactions. We did an open-label crossover clinical trial of the effect of exemestane on tamoxifen pharmacokinetics...
  18. ncbi request reprint Breast cancer prevention
    Richard R Love
    University of Wisconsin Medical School, Madison, Wisconsin 53705 2397, USA
    Oncologist 7:100-2. 2002
  19. ncbi request reprint Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women
    Hazel B Nichols
    University of Wisconsin Comprehensive Cancer Center, Madison, WI, USA
    Cancer Epidemiol Biomarkers Prev 14:41-7. 2005
    ..Our findings support the hypothesis that some breast cancer risk factors differ by ER and HER-2/neu tumor marker subtypes...
  20. pmc Public health oncology: a framework for progress in low- and middle-income countries
    R R Love
    The International Breast Cancer Research Foundation, Madison, USA
    Ann Oncol 23:3040-5. 2012
    ..The professional oncology community is being increasingly called upon to define pragmatic and realistic approaches to these problems...
  21. pmc Tamoxifen therapy in breast cancer control worldwide
    R R Love
    Department of Human Oncology, University of Wisconsin, Madison 53706
    Bull World Health Organ 71:795-803. 1993
    ..For the control of breast cancer more successfully worldwide, one challenge is to make tamoxifen therapy available to greater numbers of women...
  22. ncbi request reprint What causes cancer? Reports from sixth-grade girls
    Hazel B Nichols
    The University of Wisconsin Comprehensive Cancer Center, Madison, USA
    J Cancer Educ 21:142-6. 2006
    ..We evaluated students' perception of cancer causation among sixth-grade girls living in Wisconsin...
  23. ncbi request reprint Oophorectomy for breast cancer: history revisited
    Richard R Love
    Department of Medicine, Section of Medical Oncology, University of Wisconsin School of Medicine, Madison
    J Natl Cancer Inst 94:1433-4. 2002
  24. ncbi request reprint Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study
    Syed K Mohsin
    The Breast Center, Baylor College of Medicine, Houston, TX 77030, USA
    Mod Pathol 17:1545-54. 2004
    ..Progesterone receptor assessed by immunohistochemistry provides useful information about clinical outcome and it is better than progesterone receptor measured by ligand-binding assay...
  25. ncbi request reprint Survival after adjuvant oophorectomy and tamoxifen in operable breast cancer in premenopausal women
    Richard R Love
    Ohio State University, B402 Starling Loving Hall, 320 W 10th Ave, Columbus, OH 43210, USA
    J Clin Oncol 26:253-7. 2008
    ..Longer-term survival benefits from adjuvant therapies in such women with operable breast cancer are unknown...
  26. ncbi request reprint Meeting highlights: International Consensus Panel on the treatment of primary breast cancer
    Richard R Love
    J Clin Oncol 20:879-80. 2002
  27. ncbi request reprint Broadening our perspective on breast cancer
    Richard R Love
    Oncology (Williston Park) 21:524; author reply 524-5. 2007
  28. ncbi request reprint 'Repairing the world'--oncologists needed for foreign service
    Richard R Love
    International Breast Cancer Research Foundation, Ohio State University Comprehensive Cancer Center, USA
    Oncology (Williston Park) 21:130. 2007
  29. ncbi request reprint Breast cancer in limited-resource countries: treatment and allocation of resources
    Alexandru Eniu
    Department of Breast Tumors, Oncology, Cancer Institute I Chiricuta, Cluj Napoca, Romania
    Breast J 12:S38-53. 2006
    ..Use of the scheme outlined here should help ministers of health, policymakers, administrators, and institutions in limited-resource settings plan, establish, and gradually expand breast cancer treatment services for their populations...
  30. ncbi request reprint Meeting highlights: International consensus panel on the treatment of primary breast cancer
    Richard R Love
    J Clin Oncol 20:1955-6; author reply 1956-7. 2002
  31. ncbi request reprint Trait anxiety and tamoxifen effects on bone mineral density and sex hormone- binding globulin
    Linda D Cameron
    Department of Psychology, Faculty of Science, University of Auckland, Auckland, New Zealand
    Psychosom Med 64:612-20. 2002
    ..We assessed whether trait anxiety, a factor linked with a reactive endocrine system, is associated with differential changes in BMD and SHBG levels in response to tamoxifen therapy...
  32. ncbi request reprint Re: The influence of menstrual cycle phase on surgical treatment of primary breast cancer: have we made any progress over the past 13 years?
    Richard R Love
    J Natl Cancer Inst 94:1722-3; author reply 1723. 2002
  33. ncbi request reprint Surgical oophorectomy and breast cancer incidence
    Richard R Love
    Oncology (Williston Park) 17:1328; author reply 1328-9. 2003
  34. ncbi request reprint Population health, global bioethics and breast cancer treatment
    Richard R Love
    Oncology (Williston Park) 20:675. 2006
  35. ncbi request reprint Dilemmas in geriatrics: scenario 6 results
    D J Torgerson
    University of York
    WMJ 101:13. 2002

Research Grants2

  1. POSTDOCTORAL CANCER PREVENTION AND CONTROL TRAINING
    Richard Love; Fiscal Year: 2002
    ..Over the previous 5 years, this applicant institution has developed a good record of preparing such trainees for academic positions. ..
  2. ADJUVANT HORMONAL THERAPY IN VIETNAMESE BREAST CANCER
    Richard Love; Fiscal Year: 2005
    ..The investigators have a trial with a rich database and systems to develop further useful data on breast cancer relevant to all women. ..